PRKAA1 and atherosclerosis: While we aimed to provide clarity as to the role of myeloid AMPK in atherosclerosis, in our model, there were no statistical differences in plaque, lipid, or necrotic area between mice that had or did not have myeloid AMPK signaling or mice that were treated with or without the direct AMPK activator A-769662 in male and female mice.